VIROPHARMA INC | 21,146 Euro | -0,057 -0,27 % | |
| WKN: 903906 ISIN: US9282411084 Ticker-Symbol: VPH | Frankfurt | 19.06.13 | 09:03 Uhr |
Branche PharmaAktienmarkt NASDAQ Biotech |
|
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 18.06. | ViroPharma Up on Takeover Rumors | 1 | Zacks | |
| 18.06. | SmarTrend Watching for Potential Pullback in Shares of Viropharma After 6.30% Gain | 2 | SmarTrend | |
| 17.06. | Why ViroPharma Shares Spiked | 2 | Motley Fool | |
| 17.06. | UPDATE 1-Niche drugmaker ViroPharma attracts takeover interest -sources | 4 | Reuters.com | |
| 17.06. | ViroPharma Shares Rise on Report of Drug Company Deal Interest | 7 | Bloomberg | |
| 17.06. | Orphan drugmaker ViroPharma attracts takeover interest -sources | 9 | Reuters.com | |
| 13.06. | The Zacks Analyst Blog Highlights:ViroPharma, ExxonMobil, Summit Midstream Partners, Enerplus and Ferrellgas Partners | 11 | PR Newswire | |
| CHICAGO, June 13, 2013 /PRNewswire/ --Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting... Mehr lesen zu: The Zacks Analyst Blog Highlights:ViroPharma, ExxonMobil, Summit Midstream Partners, Enerplus and Ferrellgas Partners | ||||
| 12.06. | Orphan Drug Status for ViroPharma's Maribavir | 1 | Zacks | |
| 11.06. | Potential ViroPharma drug receives orphan status | - | Yahoo-USA | |
| 11.06. | ViroPharma drug gets orphan designation | 3 | bizjournals | |
| 11.06. | ViroPharma Receives Orphan Drug Designation for Maribavir from EC | - | Benzinga.com | |
| 11.06. | ViroPharma Receives Orphan Drug Designation For Maribavir In Europe | 69 | PR Newswire | |
| EXTON, Pennsylvania, June 11, 2013 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that the European Commission has granted orphan drug designation for maribavir for treatment... Mehr lesen zu: ViroPharma Receives Orphan Drug Designation For Maribavir In Europe | ||||
| 05.06. | Viropharma Bearish Moving Average Crossover Alert | 1 | SmarTrend | |
| 31.05. | ViroPharma To Participate In Several June Healthcare Investor Conferences | 59 | PR Newswire | |
| EXTON, Pa., May 31, 2013 /PRNewswire/ --ViroPharma Incorporated (Nasdaq: VPHM) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present at the Jefferies... Mehr lesen zu: ViroPharma To Participate In Several June Healthcare Investor Conferences | ||||
| 31.05. | Regulatory Wins, Leadership Changes, and New Partnerships Creating Healthy Prospects - Research Report on Gilead, Biogen Idec, GlaxoSmithKline, Viropharma, and Celsion | 151 | PR Newswire | |
| NEW YORK, May 31, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Today, Wall Street Reports announced new research reports highlighting Gilead... Mehr lesen zu: Regulatory Wins, Leadership Changes, and New Partnerships Creating Healthy Prospects - Research Report on Gilead, Biogen Idec, GlaxoSmithKline, Viropharma, and Celsion | ||||
| 28.05. | ViroPharma Presents New Data Analyses From Clinical Trials Of Cinryze | 79 | AFX News | |
| WASHINGTON (dpa-AFX) - Biopharmaceutical company ViroPharma Inc. (VPHM)
Tuesday presented the new data analyses from the randomized, placebo-controlled
and open label clinical trials of... Mehr lesen zu: ViroPharma Presents New Data Analyses From Clinical Trials Of Cinryze | ||||
| 24.05. | VIROPHARMA INC - 8-K, Current Report | 2 | SEC Filings | |
| 16.05. | ViroPharma unterstützt den HAE Day :-) 2013 und bringt zusammen mit HAEi Menschen weltweit zum lächeln | 78 | news aktuell | |
| München (ots/PRNewswire) - Der HAE Day :-) am 16. Mai 2013 soll das öffentliche Bewusstsein für das hereditäre Angioödem (HAE) schärfen Schicken Sie HAE-Betroffenen auf http://www.haeday.org... Mehr lesen zu: ViroPharma unterstützt den HAE Day :-) 2013 und bringt zusammen mit HAEi Menschen weltweit zum lächeln | ||||
| 16.05. | ViroPharma Proudly Supports HAE Day :-) 2013 | 59 | PR Newswire | |
| MAIDENHEAD, England, May 16, 2013 /PRNewswire/ --
HAE Day:-)takes place on 16 May 2013 and aims to raise awareness of Hereditary Angioedema (HAE)
ViroPharma Incorporated (NASDAQ: VPHM), today announced... Mehr lesen zu: ViroPharma Proudly Supports HAE Day :-) 2013 | ||||
| 15.05. | Viropharma's CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript) | 1 | Seeking Alpha | |
Seite: 1 2 3 4 5 ... Weiter >>
102 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von